Table 3 Comparison of clinical and demographic characteristics of patients with positive cytomegalovirus antigenemia according to the outcome: survivor or death

Age^b (years)

44.3 ± 23.4

35.5 ± 18.3

Lymphocyte Count (/μL)^b

447.2 ± 368.2

870.3 ± 692.9

CMV-Ag^b,c

113 ± 205,2

29 ± 52.9

Oral glucocorticosteroids (mg/ day)^a,b

107 ± 55.4

71.7 ± 46.3

 Yes

3 (30%)

8 (72.2%)

 No

7 (70%)

4 (36.6%)

Hospitalization time^b

24.3 ± 23.9

56.6 ± 35.1

Hospitalization time until CMV-Ag be requested (days)^b

9.9 ± 14

12.9 ± 10.5

Time of symptoms until CMV-Ag be requested (days)^b

7.9 ± 8.2

7.8 ± 6.4

Time from the first positive CMV-Ag to specific treatment be started (days) ^b

3.4 ± 2.6

3.3 ± 3.7

 Cytopenia

2 (20%)

4 (36.4%)

 Cytopenia e GIT

0 (0)

1 (9.1%)

 GIT

2 (20%)

3 (27.3%)

 Pneumonia

4 (40%)

4 (36.3%)

 Cytopenia e Pneumonia

2 (20%)

0 (0)